Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Adam S. Kibel, MD


Surgical Oncology

No Ratings Available - Why Not? Make an Appointment

Physician

  • Disease Center Leader, Urology
  • Chief, Urologic Surgery, Brigham and Women's Hospital
  • Professor of Surgery, Harvard Medical School

Centers/Programs

Clinical Interests

  • Bladder cancer
  • Kidney cancer
  • Minimally-invasive surgical treatments for urologic cancers
  • Prostate cancer
  • Robotic surgery for urologic cancers
  • Testicular cancer

Contact Information

  • Appointments877-332-4294 (new)
    617-525-7697 (follow-up)
  • Office Phone Number617-732-6665
  • Fax617-566-3475

Board Certification:

  • Urology, 2001

Fellowship:

  • Johns Hopkins Hospital, Urologic Oncology

Residency:

  • Brigham and Women's Hospital, General Surgery
  • Harvard Program in Urology

Medical School:

  • Cornell University Medical School

Research

Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium. J Urol. 2021 Aug 26; 101097JU0000000000002176.
View in: PubMed

Adverse Histopathologic Characteristics in Small Papillary Renal Cell Carcinomas Have Minimal Impact on Prognosis. Am J Clin Pathol. 2021 Aug 23.
View in: PubMed

A Selective Androgen Receptor Modulator (OPK-88004) in Prostate Cancer Survivors: A Randomized Trial. J Clin Endocrinol Metab. 2021 Jul 13; 106(8):2171-2186.
View in: PubMed

The translational and regulatory development of an implantable microdevice for multiple drug sensitivity measurements in cancer patients. IEEE Trans Biomed Eng. 2021 Jul 09; PP.
View in: PubMed

Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24. Prostate Cancer Prostatic Dis. 2021 Jun 14.
View in: PubMed

Cyclophosphamide-associated bladder cancers and considerations for survivorship care: A systematic review. Urol Oncol. 2021 Jun 13.
View in: PubMed

Domain adaptation for segmentation of critical structures for prostate cancer therapy. Sci Rep. 2021 Jun 01; 11(1):11480.
View in: PubMed

Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation. J Natl Cancer Inst. 2021 Jun 01; 113(6):719-726.
View in: PubMed

A Pilot Study of Multidimensional Diffusion MRI for Assessment of Tissue Heterogeneity in Prostate Cancer. Invest Radiol. 2021 May 27.
View in: PubMed

One-year urinary and sexual outcome trajectories among prostate cancer patients treated by radical prostatectomy: a prospective study. BMC Urol. 2021 May 17; 21(1):81.
View in: PubMed

Effect of Medicaid Expansion on Receipt of Definitive Treatment and Time to Treatment Initiation by Racial and Ethnic Minorities and at Minority-Serving Hospitals: A Patient-Level and Facility-Level Analysis of Breast, Colon, Lung, and Prostate Cancer. JCO Oncol Pract. 2021 05; 17(5):e654-e665.
View in: PubMed

KLK3 SNP-SNP interactions for prediction of prostate cancer aggressiveness. Sci Rep. 2021 Apr 29; 11(1):9264.
View in: PubMed

Is Medicaid expansion associated with increases in palliative treatments for metastatic cancer? J Comp Eff Res. 2021 06; 10(9):733-741.
View in: PubMed

Impact of Pathogenic Germline DNA Damage Repair alterations on Response to Intense Neoadjuvant Androgen Deprivation Therapy in High-risk Localized Prostate Cancer. Eur Urol. 2021 Sep; 80(3):295-303.
View in: PubMed

Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer. J Natl Cancer Inst. 2021 Apr 01.
View in: PubMed

Delay in surgery for cT1b-2 kidney cancer beyond 90 days is associated with poorer survival: implications for prioritization during the COVID-19 pandemic. Minerva Urol Nephrol. 2021 06; 73(3):404-406.
View in: PubMed

EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer. Nat Cancer. 2021 Apr; 2(4):444-456.
View in: PubMed

Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinoma. Urol Oncol. 2021 07; 39(7):436.e1-436.e10.
View in: PubMed

Reply by Authors. J Urol. 2021 05; 205(5):1274.
View in: PubMed

Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer. J Urol. 2021 07; 206(1):80-87.
View in: PubMed

Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nat Genet. 2021 Mar; 53(3):413.
View in: PubMed

Videos of Sipuleucel-T Programmed T Cells Lysing Cells That Express Prostate Cancer Target Antigens. J Natl Cancer Inst. 2021 Feb 25.
View in: PubMed

Polygenic hazard score is associated with prostate cancer in multi-ethnic populations. Nat Commun. 2021 02 23; 12(1):1236.
View in: PubMed

Outcomes of Post-Neoadjuvant Intense Hormone Therapy and Surgery for High Risk Localized Prostate Cancer: Results of a Pooled Analysis of Contemporary Clinical Trials. J Urol. 2021 06; 205(6):1689-1697.
View in: PubMed

Systematic Review of Time to Definitive Treatment for Intermediate Risk and High Risk Prostate Cancer: Are Delays Associated with Worse Outcomes? J Urol. 2021 May; 205(5):1263-1274.
View in: PubMed

Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer. Prostate Cancer Prostatic Dis. 2021 06; 24(2):532-541.
View in: PubMed

Insulinemic and Inflammatory Dietary Patterns and Risk of Prostate Cancer. Eur Urol. 2021 03; 79(3):405-412.
View in: PubMed

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nat Genet. 2021 01; 53(1):65-75.
View in: PubMed

The impact of smoking on radical cystectomy complications increases in elderly patients. Cancer. 2021 May 01; 127(9):1387-1394.
View in: PubMed

Health care spending in prostate cancer: An assessment of characteristics and health care utilization of high resource-patients. Urol Oncol. 2021 02; 39(2):130.e17-130.e24.
View in: PubMed

Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers. JAMA Netw Open. 2020 12 01; 3(12):e2030072.
View in: PubMed

Recovery from minimally invasive vs. open surgery in kidney cancer patients: Opioid use and workplace absenteeism. Investig Clin Urol. 2021 Jan; 62(1):56-64.
View in: PubMed

Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum. Mol Cancer Res. 2021 03; 19(3):475-484.
View in: PubMed

The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor. Cancers (Basel). 2020 Nov 04; 12(11).
View in: PubMed

Mobile Health App for Prostate Cancer Patients on Androgen Deprivation Therapy: Qualitative Usability Study. JMIR Mhealth Uhealth. 2020 11 03; 8(11):e20224.
View in: PubMed

Access denied: The relationship between patient insurance status and access to high-volume hospitals. Cancer. 2021 02 15; 127(4):577-585.
View in: PubMed

Association of surgical approach and prolonged opioid prescriptions in patients undergoing major pelvic cancer procedures. BMC Surg. 2020 Oct 14; 20(1):235.
View in: PubMed

'Case of the Month' from Brigham and Women's Hospital, Boston, MA, USA: a 70-year-old man with lung cysts and bilateral renal masses. BJU Int. 2020 10; 126(4):428-432.
View in: PubMed

African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer. Int J Cancer. 2021 01 01; 148(1):99-105.
View in: PubMed

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I. J Urol. 2021 Jan; 205(1):14-21.
View in: PubMed

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II. J Urol. 2021 Jan; 205(1):22-29.
View in: PubMed

A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data. Cancer Epidemiol Biomarkers Prev. 2020 09; 29(9):1731-1738.
View in: PubMed

Delayed blood transfusion is associated with mortality following radical cystectomy. Scand J Urol. 2020 Aug; 54(4):290-296.
View in: PubMed

The effect of sample size on polygenic hazard models for prostate cancer. Eur J Hum Genet. 2020 10; 28(10):1467-1475.
View in: PubMed

AUTHOR REPLY. Urology. 2020 Jun; 140:121.
View in: PubMed

A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry. Eur Urol. 2020 09; 78(3):316-320.
View in: PubMed

EDITORIAL COMMENT. Urology. 2020 May; 139:42-43.
View in: PubMed

Workplace absenteeism amongst patients undergoing open vs. robotic radical prostatectomy, hysterectomy, and partial colectomy. Surg Endosc. 2021 04; 35(4):1644-1650.
View in: PubMed

Alvimopan Is Associated With a Reduction in Length of Stay and Hospital Costs for Patients Undergoing Radical Cystectomy. Urology. 2020 Jun; 140:115-121.
View in: PubMed

Quantifying the Overall Survival Benefit With Early Radical Cystectomy for Patients With Histologically Confirmed T1 Non-muscle-invasive Bladder Cancer. Clin Genitourin Cancer. 2020 12; 18(6):e651-e659.
View in: PubMed

Geographic Distribution of Racial Differences in Prostate Cancer Mortality. JAMA Netw Open. 2020 03 02; 3(3):e201839.
View in: PubMed

miR-218 Expressed in Endothelial Progenitor Cells Contributes to the Development and Repair of the Kidney Microvasculature. Am J Pathol. 2020 03; 190(3):642-659.
View in: PubMed

Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer: The MEAL Randomized Clinical Trial. JAMA. 2020 01 14; 323(2):140-148.
View in: PubMed

Minimally invasive cancer surgery is associated with a lower risk of venous thromboembolic events. J Surg Oncol. 2020 Mar; 121(3):578-583.
View in: PubMed

Assessment of Out-of-Pocket Costs for Robotic Cancer Surgery in US Adults. JAMA Netw Open. 2020 01 03; 3(1):e1919185.
View in: PubMed

Delayed nephrectomy has comparable long-term overall survival to immediate nephrectomy for cT1a renal cell carcinoma: A population-based analysis. Urol Oncol. 2020 03; 38(3):74.e13-74.e20.
View in: PubMed

Facility-Level Variation in Pelvic Lymphadenectomy During Radical Prostatectomy and Effect on Overall Survival in Men with High-Risk Prostate Cancer. Ann Surg Oncol. 2020 Jun; 27(6):1929-1936.
View in: PubMed

Risk of dementia following androgen deprivation therapy for treatment of prostate cancer. Prostate Cancer Prostatic Dis. 2020 09; 23(3):410-418.
View in: PubMed

Risk factors and reasons for reoperation after radical cystectomy. Urol Oncol. 2020 04; 38(4):269-277.
View in: PubMed

Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial. Pract Radiat Oncol. 2020 Mar - Apr; 10(2):e82-e90.
View in: PubMed

Differences in survival and impact of adjuvant chemotherapy in patients with variant histology of tumors of the renal pelvis. World J Urol. 2020 Sep; 38(9):2227-2236.
View in: PubMed

Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma. J Immunother Cancer. 2019 11 07; 7(1):289.
View in: PubMed

The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years. Cancer. 2020 02 01; 126(3):496-505.
View in: PubMed

Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy. Eur Urol Oncol. 2021 Feb; 4(1):66-72.
View in: PubMed

Trends in Adherence to Thromboprophylaxis Guideline in Patients Undergoing Radical Cystectomy. Urology. 2020 Jan; 135:44-49.
View in: PubMed

Adverse Histopathologic Characteristics in Small Clear Cell Renal Cell Carcinomas Have Negative Impact on Prognosis: A Study of 631 Cases With Clinical Follow-up. Am J Surg Pathol. 2019 10; 43(10):1413-1420.
View in: PubMed

Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup. J Urol. 2020 03; 203(3):522-529.
View in: PubMed

Publisher Correction: Shared heritability and functional enrichment across six solid cancers. Nat Commun. 2019 Sep 23; 10(1):4386.
View in: PubMed

Comparing the Association Between Insurance and Mortality in Ovarian, Pancreatic, Lung, Colorectal, Prostate, and Breast Cancers. J Natl Compr Canc Netw. 2019 09 01; 17(9):1049-1058.
View in: PubMed

Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function. Proc Natl Acad Sci U S A. 2019 07 16; 116(29):14573-14582.
View in: PubMed

Contemporary national trends in prostate cancer risk profile at diagnosis. Prostate Cancer Prostatic Dis. 2020 03; 23(1):81-87.
View in: PubMed

Variation in Positive Surgical Margin Status After Radical Prostatectomy for pT2 Prostate Cancer. Clin Genitourin Cancer. 2019 10; 17(5):e1060-e1068.
View in: PubMed

The association of marital status and mortality among men with early-stage prostate cancer treated with radical prostatectomy: insight into post-prostatectomy survival strategies. Cancer Causes Control. 2019 Aug; 30(8):871-876.
View in: PubMed

Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy. Eur Urol Focus. 2021 Jan; 7(1):124-131.
View in: PubMed

Comparison of Hospital Readmission After Total Hip and Total Knee Arthroplasty vs Spinal Surgery After Implementation of the Hospital Readmissions Reduction Program. JAMA Netw Open. 2019 05 03; 2(5):e194634.
View in: PubMed

The current landscape of low-value care in men diagnosed with prostate cancer: what is the role of individual hospitals? Urol Oncol. 2019 09; 37(9):575.e9-575.e18.
View in: PubMed

The bladder cancer conundrum: how do we treat the right tumour with the right treatment, at the right time? BJU Int. 2019 05; 123(5):748-749.
View in: PubMed

Recommended Cancer Screening in Accountable Care Organizations: Trends in Colonoscopy and Mammography in the Medicare Shared Savings Program. J Oncol Pract. 2019 06; 15(6):e547-e559.
View in: PubMed

Examining the relationship between complications and perioperative mortality following radical cystectomy: a population-based analysis. BJU Int. 2019 07; 124(1):40-46.
View in: PubMed

Prostate cancer in the medicare shared savings program: are Accountable Care Organizations associated with reduced expenditures for men with prostate cancer? Prostate Cancer Prostatic Dis. 2019 12; 22(4):593-599.
View in: PubMed

Facility Level Variation in Rates of Definitive Therapy for Low Risk Prostate Cancer in Men with Limited Life Expectancy: An Opportunity for Value Based Care Redesign. J Urol. 2019 04; 201(4):728-734.
View in: PubMed

Quality of Care in the Treatment of Localized Intermediate and High Risk Prostate Cancer at Minority Serving Hospitals. J Urol. 2019 04; 201(4):735-741.
View in: PubMed

Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone. J Clin Oncol. 2019 04 10; 37(11):923-931.
View in: PubMed

Comparing Long-Term Outcomes Following Radical and Partial Nephrectomy for cT1 Renal Cell Carcinoma in Young and Healthy Individuals. JNCI Cancer Spectr. 2019 Mar; 3(1):pkz003.
View in: PubMed

Association of Care at Minority-Serving vs Non-Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic Cancer in the United States. JAMA Netw Open. 2019 02 01; 2(2):e187633.
View in: PubMed

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet. 2019 02; 51(2):363.
View in: PubMed

Contemporary Survival Rates for Muscle-Invasive Bladder Cancer Treated With Definitive or Non-Definitive Therapy. Clin Genitourin Cancer. 2019 06; 17(3):e488-e493.
View in: PubMed

Shared heritability and functional enrichment across six solid cancers. Nat Commun. 2019 01 25; 10(1):431.
View in: PubMed

Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry. Nat Commun. 2019 01 17; 10(1):382.
View in: PubMed

A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Intravenous Acetaminophen Versus Placebo in Patients Undergoing Robotic-Assisted Laparoscopic Prostatectomy. J Pain Palliat Care Pharmacother. 2018 Jun - Sep; 32(2-3):82-89.
View in: PubMed

Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival? Cancer. 2019 04 15; 125(8):1319-1329.
View in: PubMed

Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter? Cancer. 2019 05 01; 125(9):1449-1458.
View in: PubMed

Re: Association of Robotic-Assisted vs Laparoscopic Radical Nephrectomy with Perioperative Outcomes and Health Care Costs, 2003 to 2015. Eur Urol. 2019 04; 75(4):696-697.
View in: PubMed

AA9int: SNP interaction pattern search using non-hierarchical additive model set. Bioinformatics. 2018 12 15; 34(24):4141-4150.
View in: PubMed

Levels and patterns of self-reported and objectively-measured free-living physical activity among prostate cancer survivors: A prospective cohort study. Cancer. 2019 03 01; 125(5):798-806.
View in: PubMed

Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categories. World J Urol. 2019 Oct; 37(10):2059-2065.
View in: PubMed

Neoadjuvant Androgen Deprivation Therapy Prior to Radical Prostatectomy: Recent Trends in Utilization and Association with Postoperative Surgical Margin Status. Ann Surg Oncol. 2019 Jan; 26(1):297-305.
View in: PubMed

Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol. 2019 04; 75(4):552-555.
View in: PubMed

Germline variation at 8q24 and prostate cancer risk in men of European ancestry. Nat Commun. 2018 11 05; 9(1):4616.
View in: PubMed

Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study. Cancer Epidemiol Biomarkers Prev. 2019 01; 28(1):208-216.
View in: PubMed

Use of Preventive Health Services Among Cancer Survivors in the U.S. Am J Prev Med. 2018 12; 55(6):830-838.
View in: PubMed

Mechanisms responsible for reduced erythropoiesis during androgen deprivation therapy in men with prostate cancer. Am J Physiol Endocrinol Metab. 2018 12 01; 315(6):E1185-E1193.
View in: PubMed

Multilevel Analysis of Readmissions After Radical Cystectomy for Bladder Cancer in the USA: Does the Hospital Make a Difference? Eur Urol Oncol. 2019 07; 2(4):349-354.
View in: PubMed

The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies. Urol Oncol. 2018 11; 36(11):500.e11-500.e19.
View in: PubMed

Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men. Eur Urol. 2019 03; 75(3):399-407.
View in: PubMed

Targeting the MIF/CXCR7/AKT Signaling Pathway in Castration-Resistant Prostate Cancer. Mol Cancer Res. 2019 01; 17(1):263-276.
View in: PubMed

Implementation of a Perioperative Venous Thromboembolism Prophylaxis Program for Patients Undergoing Radical Cystectomy on an Enhanced Recovery After Surgery Protocol. Eur Urol Focus. 2020 01 15; 6(1):74-80.
View in: PubMed

Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer. Prostate Cancer Prostatic Dis. 2019 03; 22(1):125-136.
View in: PubMed

Contemporary perceptions of human papillomavirus and penile cancer: Perspectives from a national survey. Can Urol Assoc J. 2019 Feb; 13(2):32-37.
View in: PubMed

Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet. 2018 06 23; 391(10139):2525-2536.
View in: PubMed

Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era. World J Urol. 2018 Nov; 36(11):1767-1774.
View in: PubMed

Contemporary trends in the utilisation of radical prostatectomy. BJU Int. 2018 11; 122(5):726-728.
View in: PubMed

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. Nat Commun. 2018 06 11; 9(1):2256.
View in: PubMed

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet. 2018 07; 50(7):928-936.
View in: PubMed

Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association with Overall Survival. Clin Cancer Res. 2018 10 01; 24(19):4662-4671.
View in: PubMed

Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy. Eur Urol Oncol. 2018 06; 1(2):143-148.
View in: PubMed

Functional roles and potential clinical application of miRNA-345-5p in prostate cancer. Prostate. 2018 09; 78(12):927-937.
View in: PubMed

Current Staging Strategies for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma. Urol Clin North Am. 2018 May; 45(2):143-154.
View in: PubMed

Androgen Deprivation Therapy Is Associated With Prolongation of QTc Interval in Men With Prostate Cancer. J Endocr Soc. 2018 May 01; 2(5):485-496.
View in: PubMed

Liver Disease in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer. J Urol. 2018 09; 200(3):573-581.
View in: PubMed

The effect of treatment at minority-serving hospitals on outcomes for bladder cancer. Urol Oncol. 2018 05; 36(5):238.e7-238.e17.
View in: PubMed

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array. Br J Cancer. 2018 03 20; 118(6):e9.
View in: PubMed

Reassessing the value of high-volume cancer care in the era of precision medicine. Cancer. 2018 04 01; 124(7):1319-1321.
View in: PubMed

Cognitive Impairment in Men with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis. J Urol. 2018 06; 199(6):1417-1425.
View in: PubMed

Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy. JAMA Oncol. 2018 Feb 01; 4(2):225-229.
View in: PubMed

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. BMJ. 2018 01 10; 360:j5757.
View in: PubMed

The association of weight change in young adulthood and smoking status with risk of prostate cancer recurrence. Int J Cancer. 2018 05 15; 142(10):2011-2018.
View in: PubMed

Comparative effectiveness of robot-assisted vs. open radical cystectomy. Urol Oncol. 2018 03; 36(3):88.e1-88.e9.
View in: PubMed

Outcomes of Intracorporeal Urinary Diversion after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. J Urol. 2018 05; 199(5):1302-1311.
View in: PubMed

Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade. Prostate Cancer Prostatic Dis. 2018 09; 21(3):364-372.
View in: PubMed

Editorial Comment. J Urol. 2018 03; 199(3):712.
View in: PubMed

Impact of adequate pelvic lymph node dissection on overall survival after radical cystectomy: A stratified analysis by clinical stage and receipt of neoadjuvant chemotherapy. Urol Oncol. 2018 02; 36(2):78.e13-78.e19.
View in: PubMed

Associations of specific postoperative complications with costs after radical cystectomy. BJU Int. 2018 03; 121(3):428-436.
View in: PubMed

Approach to the Patient with High-Risk Prostate Cancer. Urol Clin North Am. 2017 Nov; 44(4):635-645.
View in: PubMed

Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer. J Pain Symptom Manage. 2018 02; 55(2):307-317.e1.
View in: PubMed

Variation in the use of active surveillance for low-risk prostate cancer. Cancer. 2018 Jan 01; 124(1):55-64.
View in: PubMed

Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer. PLoS One. 2017; 12(9):e0184166.
View in: PubMed

Effect of Nonurothelial Histologic Variants on the Outcomes of Radical Cystectomy for Nonmetastatic Muscle-invasive Urinary Bladder Cancer. Clin Genitourin Cancer. 2017 Aug 24.
View in: PubMed

Exploring exposure to Agent Orange and increased mortality due to bladder cancer. Urol Oncol. 2017 11; 35(11):627-632.
View in: PubMed

Variations in the Costs of Radical Cystectomy for Bladder Cancer in the USA. Eur Urol. 2018 Mar; 73(3):374-382.
View in: PubMed

Racial Disparity in Delivering Definitive Therapy for Intermediate/High-risk Localized Prostate Cancer: The Impact of Facility Features and Socioeconomic Characteristics. Eur Urol. 2018 Mar; 73(3):445-451.
View in: PubMed

Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer. JAMA Oncol. 2017 Aug 01; 3(8):1085-1093.
View in: PubMed

Pathologic correlation of transperineal in-bore 3-Tesla magnetic resonance imaging-guided prostate biopsy samples with radical prostatectomy specimen. Abdom Radiol (NY). 2017 08; 42(8):2154-2159.
View in: PubMed

Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry. J Natl Cancer Inst. 2017 08 01; 109(8).
View in: PubMed

Caution with Use of the EPIC-50 Urinary Bother Scale: How Voiding Dysfunction Modifies its Performance. J Urol. 2017 12; 198(6):1397-1403.
View in: PubMed

The Use of Prostate Specific Antigen Screening in Purchased versus Direct Care Settings: Data from the TRICARE® Military Database. J Urol. 2017 12; 198(6):1295-1300.
View in: PubMed

Intermediate Risk Prostate Cancer and Active Surveillance: Maximize Utilization while Minimizing Failure. J Urol. 2017 09; 198(3):493-495.
View in: PubMed

The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer. Cancer. 2017 Sep 15; 123(18):3532-3539.
View in: PubMed

Morbidity and Mortality of Locally Advanced Prostate Cancer: A Population Based Analysis Comparing Radical Prostatectomy versus External Beam Radiation. J Urol. 2017 11; 198(5):1061-1068.
View in: PubMed

Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration. Prostate. 2017 Jun; 77(9):1000-1011.
View in: PubMed

Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study. Cancer. 2017 Aug 01; 123(15):2850-2859.
View in: PubMed

Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder. Eur Urol. 2017 10; 72(4):483-487.
View in: PubMed

Adverse pathologic characteristics in the small renal mass: implications for active surveillance. Can J Urol. 2017 Apr; 24(2):8759-8764.
View in: PubMed

SNP interaction pattern identifier (SIPI): an intensive search for SNP-SNP interaction patterns. Bioinformatics. 2017 03 15; 33(6):822-833.
View in: PubMed

Prophylactic Antibiotics and Postoperative Complications of Radical Cystectomy: A Population Based Analysis in the United States. J Urol. 2017 08; 198(2):297-304.
View in: PubMed

Assessing robot-assisted laparoscopic prostatectomy. Lancet. 2017 02 25; 389(10071):799.
View in: PubMed

10-Year Outcomes in Localized Prostate Cancer. N Engl J Med. 2017 01 12; 376(2):178.
View in: PubMed

Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma. J Clin Oncol. 2017 Mar 10; 35(8):852-860.
View in: PubMed

The association of hypoalbuminemia with early perioperative outcomes - A comprehensive assessment across 16 major procedures. Am J Surg. 2017 Nov; 214(5):871-883.
View in: PubMed

Risk of Small Bowel Obstruction After Robot-Assisted vs Open Radical Prostatectomy. J Endourol. 2016 12; 30(12):1291-1295.
View in: PubMed

Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial. Clin Cancer Res. 2017 May 15; 23(10):2451-2459.
View in: PubMed

Neoadjuvant Enzalutamide Prior to Prostatectomy. Clin Cancer Res. 2017 May 01; 23(9):2169-2176.
View in: PubMed

Prog Urol. 2016 Nov; 26(13):676-677.
View in: PubMed

Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis. Int J Cancer. 2017 Jan 15; 140(2):322-328.
View in: PubMed

Efficacy of High-Intensity Local Treatment for Metastatic Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Analysis From the National Cancer Data Base. J Clin Oncol. 2016 10 10; 34(29):3529-3536.
View in: PubMed

Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study. Int J Cancer. 2017 Jan 01; 140(1):75-85.
View in: PubMed

NCCN Guidelines Insights: Bladder Cancer, Version 2.2016. J Natl Compr Canc Netw. 2016 10; 14(10):1213-1224.
View in: PubMed

Human vascular progenitor cells derived from renal arteries are endothelial-like and assist in the repair of injured renal capillary networks. Kidney Int. 2017 01; 91(1):129-143.
View in: PubMed

Meat, Fish, Poultry, and Egg Intake at Diagnosis and Risk of Prostate Cancer Progression. Cancer Prev Res (Phila). 2016 Dec; 9(12):933-941.
View in: PubMed

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet. 2016 12; 53(12):800-811.
View in: PubMed

Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment. J Urol. 2017 02; 197(2):376-384.
View in: PubMed

Resident Involvement in Radical Inguinal Orchiectomy for Testicular Cancer Does Not Adversely Impact Perioperative Outcomes - A Retrospective Study. Urol Int. 2017; 98(4):472-477.
View in: PubMed

Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium. Br J Cancer. 2016 08 23; 115(5):624-31.
View in: PubMed

Rare Variation in TET2 Is Associated with Clinically Relevant Prostate Carcinoma in African Americans. Cancer Epidemiol Biomarkers Prev. 2016 11; 25(11):1456-1463.
View in: PubMed

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discov. 2016 09; 6(9):1052-67.
View in: PubMed

Determinants of cancer screening in Asian-Americans. Cancer Causes Control. 2016 08; 27(8):989-98.
View in: PubMed

Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels. Int J Cancer. 2016 10 01; 139(7):1520-33.
View in: PubMed

Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer. J Clin Oncol. 2016 08 10; 34(23):2705-11.
View in: PubMed

Surgeon and Hospital Level Variation in the Costs of Robot-Assisted Radical Prostatectomy. J Urol. 2016 Oct; 196(4):1090-5.
View in: PubMed

The Effect of Resident Involvement on Surgical Outcomes for Common Urologic Procedures: A Case Study of Uni- and Bilateral Hydrocele Repair. Urology. 2016 Aug; 94:70-6.
View in: PubMed

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array. Br J Cancer. 2016 04 12; 114(8):945-52.
View in: PubMed

Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation. Nat Commun. 2016 Apr 07; 7:10979.
View in: PubMed

Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort. BMC Med. 2016 Apr 04; 14:66.
View in: PubMed

Trends of acute kidney injury after radical or partial nephrectomy for renal cell carcinoma. Urol Oncol. 2016 07; 34(7):293.e1-293.e10.
View in: PubMed

Blood lipids and prostate cancer: a Mendelian randomization analysis. Cancer Med. 2016 06; 5(6):1125-36.
View in: PubMed

Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer. Oncogene. 2016 09 08; 35(36):4807-15.
View in: PubMed

Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer. JAMA Oncol. 2016 Jan; 2(1):85-93.
View in: PubMed

Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma. Prostate. 2016 Apr; 76(5):479-90.
View in: PubMed

Causes of hospital readmissions after urologic cancer surgery. Urol Oncol. 2016 May; 34(5):236.e1-11.
View in: PubMed

Optimal timing of sipuleucel-T treatment in metastatic castration-resistant prostate cancer. Can J Urol. 2015 Dec; 22(6):8048-55.
View in: PubMed

Racial/Ethnic Disparities in Perioperative Outcomes of Major Procedures: Results From the National Surgical Quality Improvement Program. Ann Surg. 2015 Dec; 262(6):955-64.
View in: PubMed

Complications Following Common Inpatient Urological Procedures: Temporal Trend Analysis from 2000 to 2010. Eur Urol Focus. 2016 Apr; 2(1):3-9.
View in: PubMed

Treatment Decision Making in Patients with Bladder Cancer. Bladder Cancer. 2015 Oct 26; 1(2):151-158.
View in: PubMed

The Effect of Body Mass Index on Perioperative Outcomes After Major Surgery: Results from the National Surgical Quality Improvement Program (ACS-NSQIP) 2005-2011. World J Surg. 2015 Oct; 39(10):2376-85.
View in: PubMed

Calcium intake, polymorphisms of the calcium-sensing receptor, and recurrent/aggressive prostate cancer. Cancer Causes Control. 2015 Dec; 26(12):1751-9.
View in: PubMed

Suicide and accidental deaths among patients with non-metastatic prostate cancer. BJU Int. 2016 Aug; 118(2):286-97.
View in: PubMed

The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium. Cancer Causes Control. 2015 Nov; 26(11):1603-16.
View in: PubMed

Racial Disparities in End-of-Life Care Among Patients With Prostate Cancer: A Population-Based Study. J Natl Compr Canc Netw. 2015 Sep; 13(9):1131-8.
View in: PubMed

The Contemporary Incidence and Sequelae of Rhabdomyolysis Following Extirpative Renal Surgery: A Population Based Analysis. J Urol. 2016 Feb; 195(2):399-405.
View in: PubMed

Contemporary nationwide patterns of self-reported prostate-specific antigen screening in US veterans. Urol Oncol. 2015 Dec; 33(12):503.e7-15.
View in: PubMed

Temporal trends in receipt of adequate lymphadenectomy in bladder cancer 1988 to 2010. Urol Oncol. 2015 Dec; 33(12):504.e9-17.
View in: PubMed

Genome-wide association study of prostate cancer-specific survival. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1796-800.
View in: PubMed

Dose-dependent effect of androgen deprivation therapy for localized prostate cancer on adverse cardiac events. BJU Int. 2016 08; 118(2):221-9.
View in: PubMed

Medical androgen deprivation therapy and increased non-cancer mortality in non-metastatic prostate cancer patients aged =66 years. Eur J Surg Oncol. 2015 Nov; 41(11):1529-39.
View in: PubMed

Prediction of individual genetic risk to prostate cancer using a polygenic score. Prostate. 2015 Sep; 75(13):1467-74.
View in: PubMed

A Comparison of 30-Day Perioperative Outcomes in Open Versus Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Carcinoma: Analysis of 896 Patients from the American College of Surgeons-National Surgical Quality Improvement Program Database. J Endourol. 2015 Sep; 29(9):1052-8.
View in: PubMed

An evaluation of the 'weekend effect' in patients admitted with metastatic prostate cancer. BJU Int. 2015 Dec; 116(6):911-9.
View in: PubMed

Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans. Hum Mol Genet. 2015 Oct 01; 24(19):5589-602.
View in: PubMed

The Effect of Resident Involvement on Perioperative Outcomes in Transurethral Urologic Surgeries. J Surg Educ. 2015 Sep-Oct; 72(5):1018-25.
View in: PubMed

Comparison of 30-day perioperative outcomes in adults undergoing open versus minimally invasive pyeloplasty for ureteropelvic junction obstruction: analysis of 593 patients in a prospective national database. World J Urol. 2015 Dec; 33(12):2107-13.
View in: PubMed

Impact of smoking on perioperative outcomes after major surgery. Am J Surg. 2015 Aug; 210(2):221-229.e6.
View in: PubMed

New trends in the surgical management of invasive bladder cancer. Hematol Oncol Clin North Am. 2015 Apr; 29(2):253-69, viii.
View in: PubMed

Prediagnostic Body-mass Index, Smoking and Prostate Cancer Survival: A Cohort Consortium Study of Over 10,000 White Men with Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2015 Apr; 24(4):759-60.
View in: PubMed

The impact of resident involvement in male one-stage anterior urethroplasties. Urology. 2015 Apr; 85(4):937-41.
View in: PubMed

A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer. Cancer Discov. 2015 Apr; 5(4):368-79.
View in: PubMed

Urolithiasis and urinary tract infection among patients with inflammatory bowel disease: a review of US emergency department visits between 2006 and 2009. Urology. 2015 Apr; 85(4):764-70.
View in: PubMed

Burden of hospital admissions and utilization of hospice care in metastatic prostate cancer patients. Urology. 2015 Feb; 85(2):343-9.
View in: PubMed

The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial update. BJU Int. 2015 Feb; 115(2):198-205.
View in: PubMed

Effect of preoperative angina pectoris on cardiac outcomes in patients with previous myocardial infarction undergoing major noncardiac surgery (data from ACS-NSQIP). Am J Cardiol. 2015 Apr 15; 115(8):1080-4.
View in: PubMed

Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA: a contemporary population-based analysis. BJU Int. 2015 May; 115(5):713-21.
View in: PubMed

Readmissions after major urologic cancer surgery. Can J Urol. 2014 Dec; 21(6):7537-46.
View in: PubMed

Words of wisdom. Re: Enzalutamide in metastatic prostate cancer before chemotherapy. Eur Urol. 2015 Jan; 67(1):174.
View in: PubMed

Can urinary PCA3 supplement PSA in the early detection of prostate cancer? J Clin Oncol. 2014 Dec 20; 32(36):4066-72.
View in: PubMed

Contemporary nationwide patterns of self-reported prostate-specific antigen screening. JAMA Intern Med. 2014 Nov; 174(11):1839-41.
View in: PubMed

Castration-resistant prostate cancer: AUA guideline amendment. J Urol. 2015 Feb; 193(2):491-9.
View in: PubMed

The burden of skeletal-related events in patients with prostate cancer and bone metastasis. Urol Oncol. 2015 Jan; 33(1):17.e9-17.e18.
View in: PubMed

Patterns of Declining Use and the Adverse Effect of Primary Androgen Deprivation on All-cause Mortality in Elderly Men with Prostate Cancer. Eur Urol. 2015 Jul; 68(1):32-9.
View in: PubMed

Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy. Eur Urol. 2015 Jun; 67(6):1160-1167.
View in: PubMed

Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence. Eur Urol. 2015 Feb; 67(2):204-9.
View in: PubMed

Effect of minimally invasive surgery on the risk for surgical site infections: results from the National Surgical Quality Improvement Program (NSQIP) Database. JAMA Surg. 2014 Oct; 149(10):1039-44.
View in: PubMed

Defining a standard set of patient-centered outcomes for men with localized prostate cancer. Eur Urol. 2015 Mar; 67(3):460-7.
View in: PubMed

Transperineal in-bore 3-T MR imaging-guided prostate biopsy: a prospective clinical observational study. Radiology. 2015 Jan; 274(1):170-80.
View in: PubMed

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet. 2014 Oct; 46(10):1103-9.
View in: PubMed

The impact of resident involvement in minimally-invasive urologic oncology procedures. Can Urol Assoc J. 2014 Sep; 8(9-10):334-40.
View in: PubMed

Short-term perioperative outcomes of patients treated with radical cystectomy for bladder cancer included in the National Surgical Quality Improvement Program (NSQIP) database. Can Urol Assoc J. 2014 Sep; 8(9-10):E681-7.
View in: PubMed

The impact of robotic surgery on the surgical management of prostate cancer in the USA. BJU Int. 2015 Jun; 115(6):929-36.
View in: PubMed

Preventable mortality after common urological surgery: failing to rescue? BJU Int. 2015 Apr; 115(4):666-74.
View in: PubMed

Mental health outcomes in elderly men with prostate cancer. Urol Oncol. 2014 Nov; 32(8):1333-40.
View in: PubMed

Predictors of 30-day acute kidney injury following radical and partial nephrectomy for renal cell carcinoma. Urol Oncol. 2014 Nov; 32(8):1259-66.
View in: PubMed

Generalizability of established prostate cancer risk variants in men of African ancestry. Int J Cancer. 2015 Mar 01; 136(5):1210-7.
View in: PubMed

Chronic kidney disease and perioperative outcomes in urological oncological surgery. Int J Urol. 2014 Dec; 21(12):1245-52.
View in: PubMed

International Robotic Radical Cystectomy Consortium: A way forward. Indian J Urol. 2014 Jul; 30(3):314-7.
View in: PubMed

Efficacy of robot-assisted radical cystectomy (RARC) in advanced bladder cancer: results from the International Radical Cystectomy Consortium (IRCC). BJU Int. 2014 Jul; 114(1):98-103.
View in: PubMed

Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates. J Clin Oncol. 2014 Jun 20; 32(18):1889-94.
View in: PubMed

Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era. J Clin Oncol. 2014 May 10; 32(14):1419-26.
View in: PubMed

Clinical-pathologic stage discrepancy in bladder cancer patients treated with radical cystectomy: results from the national cancer data base. Int J Radiat Oncol Biol Phys. 2014 Apr 01; 88(5):1048-56.
View in: PubMed

Local treatment of high risk prostate cancer: Role of surgery and radiation therapy. Cancer. 2014 Jun 01; 120(11):1608-10.
View in: PubMed

Morbidity and mortality after benign prostatic hyperplasia surgery: data from the American College of Surgeons national surgical quality improvement program. J Endourol. 2014 Jul; 28(7):831-40.
View in: PubMed

Cytoreductive nephrectomy in patients with metastatic non-clear-cell renal cell carcinoma (RCC). BJU Int. 2014 May; 113(5b):E67-74.
View in: PubMed

Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer. PLoS Genet. 2014 Feb; 10(2):e1004129.
View in: PubMed

Propensity-matched comparison of morbidity and costs of open and robot-assisted radical cystectomies: a contemporary population-based analysis in the United States. Eur Urol. 2014 Sep; 66(3):569-76.
View in: PubMed

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Eur Urol. 2014 Jun; 65(6):1069-75.
View in: PubMed

A guide for clinicians in the evaluation of emerging molecular diagnostics for newly diagnosed prostate cancer. Rev Urol. 2014; 16(4):172-80.
View in: PubMed

The health care burden of skeletal related events in patients with renal cell carcinoma and bone metastasis. J Urol. 2014 Jun; 191(6):1678-84.
View in: PubMed

Reply to Michael Froehner's letter to the editor re: Kenneth G. Nepple, Andrew J. Stephenson, Dorina Kallogjeri, et al. Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity. Eur Urol 2013;64:372-8. Eur Urol. 2014 Mar; 65(3):e42.
View in: PubMed

Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol. 2014 Feb; 65(2):340-7.
View in: PubMed

Predicting risk of bladder cancer using clinical and demographic information from prostate, lung, colorectal, and ovarian cancer screening trial participants. Cancer Epidemiol Biomarkers Prev. 2013 Dec; 22(12):2241-9.
View in: PubMed

Early detection, PSA screening, and management of overdiagnosis. Hematol Oncol Clin North Am. 2013 Dec; 27(6):1091-110, vii.
View in: PubMed

Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501): important lessons for future trials. Cancer. 2013 Oct 15; 119(20):3610-8.
View in: PubMed

Constitutive ß-catenin activation induces male-specific tumorigenesis in the bladder urothelium. Cancer Res. 2013 Oct 01; 73(19):5914-25.
View in: PubMed

Words of wisdom. Re: Intermittent androgen suppression for rising PSA level after radiotherapy. Eur Urol. 2013 Jun; 63(6):1129-30.
View in: PubMed

Castration-resistant prostate cancer: AUA Guideline. J Urol. 2013 Aug; 190(2):429-38.
View in: PubMed

Response to Letter to the Editor. J Urol. 2013 Apr 10.
View in: PubMed

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet. 2013 Apr; 45(4):385-91, 391e1-2.
View in: PubMed

Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet. 2013 Jun 15; 22(12):2520-8.
View in: PubMed

Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity. Eur Urol. 2013 Sep; 64(3):372-8.
View in: PubMed

11C-acetate PET/CT before radical prostatectomy: nodal staging and treatment failure prediction. J Nucl Med. 2013 May; 54(5):699-706.
View in: PubMed

Reply from authors re: Manfred P. Wirth, Johannes Huber. What really matters is rarely measured: outcome of routine care and patient-reported outcomes. Eur Urol 2013;64:58-9: robot-assisted versus open radical cystectomy: beating a dead horse. Eur Urol. 2013 Jul; 64(1):60-1.
View in: PubMed

Impact of surgeon and volume on extended lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium (IRCC). BJU Int. 2013 Jun; 111(7):1075-80.
View in: PubMed

Randomized phase II trial evaluating the optimal sequencing of sipuleucel-T and androgen-deprivation therapy (ADT) in patients (pts) with biochemically recurrent prostate cancer (BRPC). J Clin Oncol. 2013 Feb 20; 31(6_suppl):34.
View in: PubMed

Clinical-pathologic stage discrepancy in patients with bladder cancer treated with radical cystectomy: Associations with clinical variables and survival. J Clin Oncol. 2013 Feb 20; 31(6_suppl):248.
View in: PubMed

Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent. Prostate Cancer. 2013; 2013:560857.
View in: PubMed

The 2011-2016 Transdisciplinary Research on Energetics and Cancer (TREC) initiative: rationale and design. Cancer Causes Control. 2013 Apr; 24(4):695-704.
View in: PubMed

Editorial comment. J Urol. 2013 Mar; 189(3):853.
View in: PubMed

Complications after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol. 2013 Jul; 64(1):52-7.
View in: PubMed

To biopsy or not to biopsy: minimizing the risk of prostate needle biopsy. J Urol. 2013 Mar; 189(3):796-7.
View in: PubMed

Randomized controlled trial of oxybutynin extended release versus placebo for urinary symptoms during intravesical Bacillus Calmette-Guérin treatment. J Urol. 2013 Apr; 189(4):1268-74.
View in: PubMed

Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care. Eur Urol. 2013 Feb; 63(2):214-30.
View in: PubMed

Urologic Clinics of North America. Castrate-resistant prostate cancer. Preface. Urol Clin North Am. 2012 Nov; 39(4):xv.
View in: PubMed

Who should be included in a clinical trial of screening for bladder cancer?: a decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Cancer. 2013 Jan 01; 119(1):143-9.
View in: PubMed

Comparative analysis of outcomes and costs following open radical cystectomy versus robot-assisted laparoscopic radical cystectomy: results from the US Nationwide Inpatient Sample. Eur Urol. 2012 Jun; 61(6):1239-44.
View in: PubMed

Androgen deprivation therapy for localized and nonmetastatic prostate cancer: too much of a good thing? Eur Urol. 2012 Jun; 61(6):1129-30; discussion 1131.
View in: PubMed

Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. J Urol. 2012 Apr; 187(4):1259-65.
View in: PubMed

Prostate cancer-specific mortality and competing causes of mortality among elderly men after local therapy for prostate cancer. J Clin Oncol. 2012 Feb 10; 30(5_suppl):103.
View in: PubMed

Impact of different definitions of high-risk prostate cancer on survival after radical prostatectomy. J Clin Oncol. 2012 Feb 10; 30(5_suppl):113.
View in: PubMed

Impact of marital status on prostate cancer-specific mortality and overall mortality after radical prostatectomy. J Clin Oncol. 2012 Feb 10; 30(5_suppl):73.
View in: PubMed

Foamy gland adenocarcinoma of the prostate: incidence, Gleason grade, and early clinical outcome. Hum Pathol. 2012 Jul; 43(7):974-9.
View in: PubMed

Ureteral injury in laparoscopic gynecologic surgery. Rev Obstet Gynecol. 2012; 5(2):106-11.
View in: PubMed

Treat now or later: the dilemma of postoperative radiotherapy. Eur Urol. 2012 Mar; 61(3):452-4.
View in: PubMed

Highlights of the 2010 SUO Annual Meeting. Urol Oncol. 2011 Nov-Dec; 29(6):825.
View in: PubMed

Indications and practice with androgen deprivation therapy. Urology. 2011 Nov; 78(5 Suppl):S478-81.
View in: PubMed

Targeting the androgen receptor--theory and practice. Urology. 2011 Nov; 78(5 Suppl):S482-4.
View in: PubMed

Prediction of erectile function following treatment for prostate cancer. JAMA. 2011 Sep 21; 306(11):1205-14.
View in: PubMed

Laparoscopic retroperitoneal lymph node dissection for low-stage cancer: a Washington University update. J Endourol. 2011 Nov; 25(11):1753-7.
View in: PubMed

Early oncologic outcomes of robotic vs. open radical cystectomy for urothelial cancer. Urol Oncol. 2013 Aug; 31(6):894-8.
View in: PubMed

Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet. 2011 Jun; 43(6):570-3.
View in: PubMed

A retrospective validation of a circulating microvesicle-based assay for the detection of prostate cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):e15172.
View in: PubMed

Design of an open-label randomized phase II trial examining the effect of sequencing of sipuleucel-T and androgen deprivation therapy (ADT) on immune markers in prostate cancer patients with a rising prostate specific antigen (PSA) after primary therapy. J Clin Oncol. 2011 May 20; 29(15_suppl):TPS189.
View in: PubMed

Words of wisdom. Re: active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. Eur Urol. 2011 May; 59(5):883-4.
View in: PubMed

Positive margin during partial nephrectomy: does cancer remain in the renal remnant? Urology. 2011 Jun; 77(6):1400-3.
View in: PubMed

Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence. Clin Cancer Res. 2011 Mar 01; 17(5):1075-81.
View in: PubMed

Lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. BJU Int. 2011 Feb; 107(4):642-6.
View in: PubMed

Ability of linear length of positive margin in radical prostatectomy specimens to predict biochemical recurrence. Urology. 2011 Jun; 77(6):1409-14.
View in: PubMed

Validation of genome-wide prostate cancer associations in men of African descent. Cancer Epidemiol Biomarkers Prev. 2011 Jan; 20(1):23-32.
View in: PubMed

Editorial for "Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50". Cancer. 2011 Mar 15; 117(6):1110-2.
View in: PubMed

Does previous robot-assisted radical prostatectomy experience affect outcomes at robot-assisted radical cystectomy? Results from the International Robotic Cystectomy Consortium. Urology. 2010 Nov; 76(5):1111-6.
View in: PubMed

The Gleason score of tumor at the margin in radical prostatectomy is predictive of biochemical recurrence. Am J Surg Pathol. 2010 Jul; 34(7):994-1001.
View in: PubMed

Counterpoint: Prostate carcinoma treatment for the young patient--The case for radical prostatectomy. Brachytherapy. 2010 Jul-Sep; 9(3):195-8; discussion 199-201.
View in: PubMed

Reply from authors re: Urs E. Studer, Laurence Collette. Robot-assisted cystectomy: does it meet expectations? Eur Urol 2010;58:203-4. Eur Urol. 2010 Aug; 58(2):204-6.
View in: PubMed

Surgical margin status after robot assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. J Urol. 2010 Jul; 184(1):87-91.
View in: PubMed

BCAN Think Tank session 3: Prevention of bladder cancer. Urol Oncol. 2010 May-Jun; 28(3):338-42.
View in: PubMed

High-risk localized prostate cancer: role of radical prostatectomy. Curr Opin Urol. 2010 May; 20(3):204-10.
View in: PubMed

Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma. Prostate. 2010 May 01; 70(6):646-53.
View in: PubMed

The learning curve of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol. 2010 Aug; 58(2):197-202.
View in: PubMed

Percent microscopic tumor necrosis and survival after curative surgery for renal cell carcinoma. J Urol. 2010 Mar; 183(3):909-14.
View in: PubMed

Risk of urinary incontinence following prostatectomy: the role of physical activity and obesity. J Urol. 2010 Feb; 183(2):629-33.
View in: PubMed

Editorial comment. J Urol. 2010 Feb; 183(2):533; discussion 533.
View in: PubMed

Effect of reclassification on the incidence of benign and malignant renal tumors. J Urol. 2010 Feb; 183(2):455-8.
View in: PubMed

Words of wisdom. Re: Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. Eur Urol. 2009 Dec; 56(6):1089-90.
View in: PubMed

The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection. Urol Oncol. 2011 Nov-Dec; 29(6):738-44.
View in: PubMed

Editorial comment. J Urol. 2009 Nov; 182(5):2194; discussion 2194.
View in: PubMed

Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol. 2009 Sep 10; 27(26):4314-20.
View in: PubMed

Intravesical bacille Calmette-Guérin therapy for non-muscle-invasive bladder cancer: effects of concurrent statin therapy. J Am Coll Surg. 2009 Aug; 209(2):248-53.
View in: PubMed

Prostate cancer risk associated loci in African Americans. Cancer Epidemiol Biomarkers Prev. 2009 Jul; 18(7):2145-9.
View in: PubMed

Highlights of the 2008 SUO/SBUR annual meeting: current controversies in urologic oncology. Urol Oncol. 2009 May-Jun; 27(3):293-4.
View in: PubMed

Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans. Magn Reson Med. 2009 Apr; 61(4):842-50.
View in: PubMed

Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis. 2009 May; 30(5):769-76.
View in: PubMed

The role of systemic cytotoxic therapy for prostate cancer. BJU Int. 2009 Jan; 103(1):8-17.
View in: PubMed

Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet. 2008 Sep; 40(9):1032-4; author reply 1035-6.
View in: PubMed

Evaluation of a novel precision template-guided biopsy system for detecting prostate cancer. BJU Int. 2008 Aug 05; 102(5):546-50.
View in: PubMed

Association between polymorphisms in cell cycle genes and advanced prostate carcinoma. Prostate. 2008 Aug 01; 68(11):1179-86.
View in: PubMed

Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma. Cancer. 2008 Aug 01; 113(3):477-83.
View in: PubMed

Laparoscopic retroperitoneal lymph node dissection for low-stage testicular cancer. J Endourol. 2008 Jul; 22(7):1485-9.
View in: PubMed

Impact of central pathology review (CPR) of radical prostatectomy (RP) specimens for patient selection in the surgical adjuvant trial in prostate cancer (PCa) TAX-3501. J Clin Oncol. 2008 May 20; 26(15_suppl):5128.
View in: PubMed

Impact of comorbidity on overall survival in patients surgically treated for renal cell carcinoma. Urology. 2008 Aug; 72(2):359-63.
View in: PubMed

Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008 Mar 20; 358(12):1250-61.
View in: PubMed

The distribution of histological subtypes of renal tumors by decade of life using the 2004 WHO classification. J Urol. 2008 Feb; 179(2):439-43; discussion 443-4.
View in: PubMed

SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum Mol Genet. 2008 Apr 01; 17(7):1031-42.
View in: PubMed

Words of wisdom. Re: EPCA-2: a highly specific serum marker for prostate cancer. Eur Urol. 2008 Jan; 53(1):210.
View in: PubMed

The Second Joint Meeting of American Urological Association (AUA)/Japanese Urological Association (JUA) International Program on the 102nd Annual Meeting of American Urological Association at Anaheim 2007. Int J Urol. 2007 Dec; 14(12):1116-23.
View in: PubMed

Prognostic impact of comorbidity in patients with bladder cancer. Eur Urol. 2008 Mar; 53(3):581-9.
View in: PubMed

Prostate cancer: screening, diagnosis and management in 2007. Mo Med. 2007 Sep-Oct; 104(5):408-13; quiz 413-4.
View in: PubMed

The use and abuse of data: nomograms and talking to patients about clinical medicine. Urol Oncol. 2007 Jul-Aug; 25(4):333-7.
View in: PubMed

Optimizing prostate biopsy techniques. J Urol. 2007 Jun; 177(6):1976-7.
View in: PubMed

Prostate-specific antigen density predicts adverse pathology and increased risk of biochemical failure. Urology. 2007 Jun; 69(6):1121-7.
View in: PubMed

Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study. J Urol. 2007 May; 177(5):1777-81.
View in: PubMed

Adjuvant and salvage treatment options for patients with high-risk prostate cancer treated with radical prostatectomy. Prostate Cancer Prostatic Dis. 2007; 10(2):119-26.
View in: PubMed

Trends in nephron-sparing surgery for renal neoplasia. Urology. 2006 Oct; 68(4):732-6.
View in: PubMed

Minimally invasive approaches to localized prostate carcinoma. Hematol Oncol Clin North Am. 2006 Aug; 20(4):879-95.
View in: PubMed

Single nucleotide polymorphisms: early diagnosis and risk assessment in genitourinary malignancy. Urol Oncol. 2006 May-Jun; 24(3):224-30.
View in: PubMed

Association of hereditary prostate cancer gene polymorphic variants with sporadic aggressive prostate carcinoma. Prostate. 2006 Jan 01; 66(1):49-56.
View in: PubMed

Laparoscopic renal surgery and the risk of rhabdomyolysis: diagnosis and treatment. Urology. 2005 Nov; 66(5 Suppl):29-35.
View in: PubMed

A pilot multicenter phase II study of adjuvant docetaxel (D) for high risk prostate cancer (PC) patients (pts) after radical prostatectomy (RP): Preliminary data. J Clin Oncol. 2005 Jun; 23(16_suppl):4565.
View in: PubMed

An interdisciplinary approach to treating prostate cancer. Urology. 2005 Jun; 65(6 Suppl):13-8.
View in: PubMed

Parenchymal imaging adds diagnostic utility in evaluating haematuria. BJU Int. 2005 Jan; 95(1):64-7.
View in: PubMed

Adjuvant weekly docetaxel (D) for high-risk prostate cancer patients (pts) after radical prostatectomy (RP): Preliminary data of a multicenter pilot trial. J Clin Oncol. 2004 Jul 15; 22(14_suppl):4649.
View in: PubMed

Expression mapping at 12p12-13 in advanced prostate carcinoma. Int J Cancer. 2004 May 01; 109(5):668-72.
View in: PubMed

Transitional cell carcinoma of the renal pelvis associated with hypercalcemia in a patient with autosomal dominant polycystic kidney disease. Urology. 2004 Apr; 63(4):778-80.
View in: PubMed

Renal sinus haemangioma with inferior vena cava involvement. BJU Int. 2003 Dec; 92 Suppl 3:e53.
View in: PubMed

Surgical treatment of renal neoplasia: evolving toward a laparoscopic standard of care. Urology. 2003 Nov; 62(5):821-6.
View in: PubMed

Modified renal morcellation for renal cell carcinoma: laboratory experience and early clinical application. Urology. 2003 Oct; 62(4):632-4; discussion 635.
View in: PubMed

Xq27-28 deletions in prostate carcinoma. Genes Chromosomes Cancer. 2003 Aug; 37(4):381-8.
View in: PubMed

CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma. Cancer Res. 2003 May 01; 63(9):2033-6.
View in: PubMed

Hemostatic laparoscopic partial nephrectomy assisted by a water-cooled, high-density, monopolar device without renal vascular control. Urology. 2003 May; 61(5):906-9.
View in: PubMed

11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. J Nucl Med. 2003 Apr; 44(4):549-55.
View in: PubMed

Laparoscopic partial nephrectomy with a novel electrosurgical snare in a porcine model. J Endourol. 2002 Nov; 16(9):673-9.
View in: PubMed

Patterns of multiple recurrences of superficial (Ta/T1) transitional cell carcinoma of bladder and effects of clinicopathologic and biochemical factors. Cancer. 2002 Sep 15; 95(6):1239-46.
View in: PubMed

Mutational analysis of ETV6 in prostate carcinoma. Prostate. 2002 Sep 01; 52(4):305-10.
View in: PubMed

Comparison of hand assisted and standard laparoscopic radical nephroureterectomy for the management of localized transitional cell carcinoma. J Urol. 2002 Jun; 167(6):2387-91.
View in: PubMed

Management of the postpubertal patient with cryptorchidism: an updated analysis. J Urol. 2002 Mar; 167(3):1329-33.
View in: PubMed

Rapid resolution of carbon dioxide pneumothorax (capno-thorax) resulting from diaphragmatic injury during laparoscopic nephrectomy. J Urol. 2002 Mar; 167(3):1387-8.
View in: PubMed

Dual-organ ablative surgery using a hand-assisted laparoscopic technique. A report of four cases. Surg Endosc. 2002 Jan; 16(1):215-6.
View in: PubMed

Methylation and mutational analysis of p27(kip1) in prostate carcinoma. Prostate. 2001 Sep 15; 48(4):248-53.
View in: PubMed

Latent prostate carcinoma in a screened population. Eur Urol. 2001 Apr; 39 Suppl 4:35-6.
View in: PubMed

Adult clear cell sarcoma of the kidney with atrial tumor thrombus. J Urol. 2001 Mar; 165(3):896-7.
View in: PubMed

Loss of heterozygosity at 12P12-13 in primary and metastatic prostate adenocarcinoma. J Urol. 2000 Jul; 164(1):192-6.
View in: PubMed

G(1)/S cell cycle proteins as markers of aggressive prostate carcinoma. Urology. 2000 Mar; 55(3):316-22.
View in: PubMed

Deletion mapping at 12p12-13 in metastatic prostate cancer. Genes Chromosomes Cancer. 1999 Jul; 25(3):270-6.
View in: PubMed

Familial calcium stone disease: TaqI polymorphism and the vitamin D receptor. J Endourol. 1999 May; 13(4):313-6.
View in: PubMed

Identification of 12p as a region of frequent deletion in advanced prostate cancer. Cancer Res. 1998 Dec 15; 58(24):5652-5.
View in: PubMed

Vitamin D receptor polymorphisms and lethal prostate cancer. J Urol. 1998 Oct; 160(4):1405-9.
View in: PubMed

Penile necrosis after coronary artery bypass grafting. Br J Urol. 1998 Mar; 81(3):508-9.
View in: PubMed

Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases. J Urol. 1998 Mar; 159(3):859-63.
View in: PubMed

Late venous thromboembolic disease after radical prostatectomy: effect of risk factors, warfarin and early discharge. J Urol. 1997 Dec; 158(6):2211-5.
View in: PubMed

Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues. Hum Pathol. 1997 Apr; 28(4):459-64.
View in: PubMed

Primary lymphoma of the bladder: a unique cystoscopic appearance. Urology. 1997 Feb; 49(2):276-8.
View in: PubMed

Constitutive expression of high levels of prostate-specific antigen in the absence of prostate carcinoma. Urology. 1996 Nov; 48(5):741-6.
View in: PubMed

Squamous cell carcinoma of the renal pelvis with inferior vena caval extension. J Urol. 1996 Oct; 156(4):1436.
View in: PubMed

Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science. 1995 Sep 08; 269(5229):1444-6.
View in: PubMed

Tumour suppression by the human von Hippel-Lindau gene product. Nat Med. 1995 Aug; 1(8):822-6.
View in: PubMed

Pathogenesis and prophylaxis of postoperative thromboembolic disease in urological pelvic surgery. J Urol. 1995 Jun; 153(6):1763-74.
View in: PubMed

Intraperitoneal bladder rupture after normal vaginal delivery. J Urol. 1995 Mar; 153(3 Pt 1):725-7.
View in: PubMed

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions

Top